BioGaia AB (publ)
SSE:BIOG-B.ST
Overview | Financials
Company Name | BioGaia AB (publ) |
Symbol | BIOG-B.ST |
Currency | SEK |
Price | 124.4 |
Market Cap | 12,101,507,600 |
Dividend Yield | 3.72% |
52-week-range | 87.95 - 128.7 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Ms. Isabelle Valerie Ghislaine Ducellier |
Website | https://www.biogaia.com |
An error occurred while fetching data.
About BioGaia AB (publ)
BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD